Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
Overview of attention for article published in Osteoporosis International, October 2012
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (89th percentile)
-
Good Attention Score compared to outputs of the same age and source (78th percentile)
Mentioned by
- policy
- 1 policy source
- 2 X users
- patent
- 2 patents
- guideline
- 2 clinical guideline sources
Readers on
- mendeley
- 98 Mendeley